Hamilton Thomas Edward
Insider CIK 1769848 · NLY Director · LRMR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-07-06 | 2026-07-08 | 50,000 | $3.34 | $167.0K | 714,798 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2026-06-10 | 2026-06-12 | 8,641 | — | $0 | 53,884 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-20 | 55,150 | — | $0 | 55,150 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2026-02-27 | 2026-03-02 | 100,000 | $5.00 | $500.0K | 664,798 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2025-05-14 | 2025-05-15 | 8,961 | — | $0 | 45,243 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2025-05-13 | 2025-05-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2024-05-29 | 2024-05-31 | 19,000 | — | $0 | 19,000 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2024-05-15 | 2024-05-17 | 8,583 | — | $0 | 36,282 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2024-02-16 | 2024-05-31 | 57,208 | $8.74 | $500.0K | 564,798 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2023-05-17 | 2023-05-19 | 8,167 | — | $0 | 27,698 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2023-05-09 | 2023-05-11 | 8,300 | — | $0 | 8,300 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-20 | 317,460 | $3.15 | $1000.0K | 507,590 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2022-05-18 | 2022-05-20 | 24,372 | — | $0 | 78,124 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2022-05-10 | 2022-05-12 | 8,300 | — | $0 | 8,300 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2021-06-30 | 2021-07-02 | 56,710 | $8.75 | $496.2K | 190,130 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2021-05-19 | 2021-05-21 | 15,609 | — | $0 | 53,752 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2021-05-12 | 2021-05-17 | 8,300 | — | $0 | 8,300 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | S Sale | 2021-05-03 | 2021-05-04 | 80,000 | $9.18 | $734.4K | 0 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2020-09-29 | 2020-09-30 | 16,600 | — | $0 | 16,600 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | J Other | 2020-06-26 | 2020-06-30 | 133,420 | — | $0 | 133,420 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | J Other | 2020-06-26 | 2020-06-30 | 159,433 | — | $0 | 292,853 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2020-05-20 | 2020-05-22 | 22,551 | — | $0 | 38,143 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | P Buy | 2020-05-15 | 2020-05-15 | 200,000 | $5.96 | $1.19M | 330,000 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | A Award deriv | 2019-05-22 | 2019-05-24 | 15,592 | — | $0 | 15,592 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | P Buy | 2019-05-17 | 2019-05-20 | 30,000 | $9.47 | $284.1K | 130,000 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | P Buy | 2019-05-17 | 2019-05-20 | 30,000 | $9.47 | $284.1K | 80,000 | SEC↗ |
| NLY ANNALY CAPITAL MANAGEMENT | P Buy | 2019-05-17 | 2019-05-20 | 30,000 | $9.47 | $284.1K | 130,000 | SEC↗ |